Company: BL
Filing Date: 2025-05-07
Form Type: 10-Q
Source: 0001666134-25-000016
Chunk: 10

Company: BLACKLINE, INC.
Filing Date: 2025-05-07
Form: 10-Q
Item: Part I, Item 1
Chunk 10
---
ensive patent2,333 (1,577)756 $182,807 $(126,937)$55,870 December 31, 2024Gross Carrying AmountAccumulated AmortizationNet Carrying AmountTrade name$15,977 $(15,977)$— Developed technology137,718 (80,284)57,434 Customer relationships26,779 (25,528)1,251 Defensive patent2,333 (1,498)835 $182,807 $(123,287)$59,520 The following table represents the changes in goodwill (in thousands): Balance at December 31, 2024$448,965 Additions from acquisitions— Balance at March 31, 2025$448,965 

Note 6 – Balance Sheet Components

Investments in Marketable SecuritiesAt March 31, 2025, investments in marketable securities presented within current assets on the unaudited condensed consolidated balance sheets consisted of the following (in thousands):March 31, 2025AmortizedCostGrossUnrealizedGainsGrossUnrealizedLossesFair ValueMarketable securitiesU.S. treasury securities$254,692 $63 $(8)$254,747 Commercial paper132,198 — — 132,198 $386,890 $63 $(8)$386,945 The Company had no marketable securities at December 31, 2024.The Company’s marketable securities at March 31, 2025 have a contractual maturity of less than one year. All of our available-for-sale securities are available for use in our current operations and are categorized as current assets. Refer to “Note 7 - Fair Value Measurements” for additional information. The Company recognized accretion on its marketable securities of $2.0 million in interest income for the quarter ended March 31, 2025. The Company recognized accretion on its marketable securities in interest income, and also recognized net gains and losses related to maturities of marketable securities that were reclassified from accumulated other comprehensive loss in interest income of $8.5 million for the quarter ended March 31, 2024.Net gains and losses are determined using the specific identification method. During the quarters ended March 31, 2025 and 2024, there were no realized gains and losses related to sales of marketable securities recognized in the Company